Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | C110 - Spinocerebellar and Spastic Ataxias: Diagnosis and Management

Tuesday 04/16/24
07:00 AM - 09:00 AM MDT Add To Calendar
Colorado Convention Center | 605
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Oksana Suchowersky, MD, FAAN
Movement Disorders
Participants should become familiar with the differential diagnoses, investigation, and management of patients with hereditary spinocerebellar and spastic ataxias. Particular attention will be given to benefits and limitations of genetic testing, different types of genetic testing, update on pathophysiology, and potential for new and genetic therapies.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Quality Improvement
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Medical Student
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:40 AM MDT Speaker The Autosomal Dominant Spinocerebellar Ataxias: Diagnosis and Treatment
Oksana Suchowersky, MD, FAAN
07:40 AM - 08:20 AM MDT Speaker The Recessive Spinocerebellar Ataxias; Diagnosis and Treatment
Massimo Pandolfo, MD, FAAN
08:20 AM - 08:40 AM MDT Discussion Case Presentations
Oksana Suchowersky, MD, FAAN
08:40 AM - 09:00 AM MDT Discussion Case Presentations
Massimo Pandolfo, MD, FAAN
Faculty Disclosures
Oksana Suchowersky, MD, FAAN Dr. Suchowersky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos/Alexion. The institution of Dr. Suchowersky has received research support from Roche. The institution of Dr. Suchowersky has received research support from Wave LifeSciences. The institution of Dr. Suchowersky has received research support from CHDI. Dr. Suchowersky has received publishing royalties from a publication relating to health care. Dr. Suchowersky has received publishing royalties from a publication relating to health care.
Massimo Pandolfo, MD, FAAN Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Minoryx. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Design Therapeutics . Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Reata. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biomarin. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Design Therapeutics. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Pandolfo has stock in Voyager Therapeutics. The institution of Dr. Pandolfo has received research support from Freidreich Ataxaia Research Alliance. Dr. Pandolfo has a non-compensated relationship as a Scientific Advisory Board with Friedreich Ataxia Research Alliance that is relevant to AAN interests or activities. Dr. Pandolfo has a non-compensated relationship as a Member-Meeting Management Committee with AAN that is relevant to AAN interests or activities.